ZEALAND PHARMA A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 915.50 DKK | +1.61% |
|
+10.57% | +145.31% |
| 09-09 | Zealand Pharma's Weight Management Drug Shows Positive Topline Results in Early-stage Trial | MT |
| 09-09 | Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight | MT |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 7 | |||||||||
| 25 | |||||||||
| 29 | |||||||||
| 15 | |||||||||
| 18 | |||||||||
| 21 | |||||||||
| 17 | |||||||||
| 18 | |||||||||
| - | - | - | 7 | ||||||
| 16 | |||||||||
| 25 | |||||||||
| 19 | |||||||||
| 19 | |||||||||
| - | - | - | - | ||||||
| 10 | |||||||||
| 21 | |||||||||
| 4 | |||||||||
| - | 13 | ||||||||
| 13 | |||||||||
| Average | 16 | ||||||||
| Weighted average by Cap. | 22 |
- Stock Market
- Equities
- ZEAL Stock
- Sector Zealand Pharma A/S
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition